Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols

Barboy O, Bercovich A, Li H, Eyal-Lubling Y, Yalin A, Shapir Itai Y, Abadie K, Zada M, David E, Shlomi-Loubaton S, Katzenelenbogen Y, Adhemar Jaitin D, Gur C, Yofe I, Feferman T, Cohen M, Dahan R, Newell EW, Lifshitz A, Tanay A & Amit I: Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols. Nat Cancer 5(5):742-759; doi: 10.1038/s43018-024-00734-z (2024).

Categorised in:

This post was written by redakteur